SUMAYYA EBRAHIM GYNAECOLOGIST PARKLANE CLINIC JOHANNESBURG

Slides:



Advertisements
Similar presentations
Which of the following increases a women’s risk for Breast Cancer? A.Starting her menses at age 14 or older B.Breastfeeding C.Extremely dense breast tissue.
Advertisements

Breast Cancer. Dr. Swapna Chaudhary M.S. (MUM) M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
1 Female Reproductive Disorders. 2 Problems Related to Menstruation Premenstrual Syndrome Dysmenorrhea Oligomenorrhea Amenorrhea Menorrhagia Metrorrhagia.
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
Princess Alexandra Hospitals NHS Trust Breast Unit Family History Clinic.
High Risk Ad Hoc Workgroup Research and findings presented to the Federal Advisory Committee on Breast Cancer in Young Women April 2012.
Breast & Ovarian Cancer: BRCA1 and BRCA2
Hereditary Factors in Breast Cancer
Hereditary breast and ovarian cancer Who should be screened and How? Symposium on Cancer Waterloo Inn October 31, 2007 Mala Bahl, MD, MSc.
Breast Cancer Risk and Risk Assessment Models
Hereditary Breast and Ovarian Cancer Syndrome. Background Information 10% of ovarian cancer is genetic 5% of breast cancer is genetic BRCA 1 and 2.
Type Of Cancer:Location: CarcinomaEpithelial Cells SarcomaConnective Tissue LeukemiaCirculatory / Lymphatic.
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Cancer Genetics for Primary Care Sara Levene Registered Genetic Counsellor.
Breast Cancer Liz Ignatious, Maddie Ticer, Molly Houlahan.
OVARIAN CANCER Talking point: Genetics of ovarian cancer.
Ovarian cancer….. in 15 minutes
Breast cancer screening Recommendations for breast cancer screening چه شواهدی برای خطر وجود دارد؟ برای غربالگری چه باید کرد؟
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
Genetics and Risk of Breast Cancer What is the Evidence.
 It is benign uterine tumour consist of smooth muscles,it can present anywhere in the uterine wall.it could be intrmural,subserosal,  Submucosal,cervical.
Breast Screening. NHS Breast Screening Programme Introduced in 1988 Invites women from age group for screening every 3 yrs. Age extension roll-out.
Breast Cancer By George Rezk.
Breast Cancer Risk Factors
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
Breast Cancer Hitham G. Falahi 4NU04. The most common cancer in females…
BREAST CANCER AWARENESS Sheraton Kuwait , Crystal Ballroom
BREAST CANCER GROUP 6 :  Nuraini Ikqtiarzune Haryono( )  Tri Wahyu Ningsih ( )  Rani Yuswandaru ( )  Anita Rheza Fitriana Putri( )
Jo Anne Zujewski, MD Center for Global Health National Cancer Institute, U.S.A. Dar es Salaam September 11, 2014 Breast Cancer Risk Factors and Prevention.
Early Detection Is Your Best Protection. Breast Cancer Statistics for Women A woman has a one in eight chance of developing breast cancer in her lifetime.
Menopause: The Journal of The North American Menopause Society
What’s new in Breast Disease M. Whitney Parnell MD FACS Surgical Associates of Myrtle Beach Breast and General Surgery.
Hysterectomy for Undergraduates
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.
Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences.
Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.
Breast Cancer Methods for Early Detection. Breast Cancer What It Is Methods of Early Detection Risk Factors.
Management of ovarian cysts
Breast cancer -most common -Second common ( Death ) new case ( 2003 ) diagnosed - Lifetime Risk 2.5 % ( 1-8 )
IN THE NAME OF GOD BREAST DISEASE E.Naghshineh M.D.
National Breast Cancer Awareness Month sources: National Cancer Institute ( and American Cancer Society ( Employee Wellness.
Breast Cancer By: Christen Scott.
Shiva Sharma SHO to Professor Redmond.  Introduction  Increased risk groups  Consideration of genetic testing  Management of patients with mutation.
Personal Risk Factors Gender being a woman is the main risk factor for developing breast cancer (100 times more common in women) Age occurrence increase.
BRCA1 and BRCA2 are genes which normally help to prevent breast cancer by making proteins which inhibit abnormal cellular growth. While a woman with an.
Breast Ovarian Hereditary Breast & Ovarian Cancer Knowing one’s family medical history can be life-saving.
Gynecological Malignancies. Gynecologic malignancies account for 15% of all cancers in women. Gynecologic malignancies account for 15% of all cancers.
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
The breast disease. Benign disease Present as; 1. Pain 2. Mass 3. Discharge 4. Abnormal appearance.
Breast Cancer Screening. Introduction Breast cancer is a fatal disease at advanced stages; however, it can be controlled through prevention and early.
Breast Cancer »Breast cancer is a malignant tumor that starts in the cells of the breast. »The disease occurs almost entirely in women,but men can get.
Mark Browning, M.D. IUSME.  22,000 Cases  14,000 Deaths  Overall Survival Rate is 35%  Survival Rate Depends on Stage.
By: Anthony, Sophia, Jessica, Terrance, and Sierra.
The Elliott Breast Center * Baton Rouge, LA *
Ovarian Cancer aka “The disease that whispers” Statistics The average age when ovarian cancer is detected in women is 56.3 years. Less than 1 out of.
The most proven way to fight breast cancer is early detection!
Breast Cancer Risk Assessment & Prevention Strategies Generosa Grana, MD Professor, Cooper Medical School of Rowan University Director, MD Anderson Cancer.
Beaumont Hospital Breast Service
Screening for Ovarian Cancer
Breast Cancer Updates Risks, Genetics, DCIS
Breast Cancer Protocol
Surgical Management of the Breast in Breast Cancer
Breast Screening and Risk Assessment
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
Breast Cancer Screening
Prophylactic Oophorectomy
Principles and Practice of Radiation Therapy
Presentation transcript:

SUMAYYA EBRAHIM GYNAECOLOGIST PARKLANE CLINIC JOHANNESBURG The Angelina Jolie Example : Risk Reducing Surgery for Breast and Ovarian Cancer SUMAYYA EBRAHIM GYNAECOLOGIST PARKLANE CLINIC JOHANNESBURG

MAY 2013

STATISTICS SOUTH AFRICA NATIONAL CANCER REGISTRY Lifetime risk of ovarian cancer 1:82 Lifetime risk of breast cancer 1:29 (2004)

GENETIC CANCERS BRCA 1 and BRCA2 mutations: 5-10% breast cancers 10-15% ovarian cancers (white women in USA)

BRCA Tumour supressor gene Breast cancer susceptibility gene 1 (BRCA 1) Breast cancer susceptibility gene 2 (BRCA 2)

INCIDENCE OF BRCA BRCA 1 general population 1:500-1:800 BRCA 2 lower Ashkanazi Jewish Descent 1:40

CANCER RISKS WITH BRCA Increased cancer risk Breast cancer risk 5x higher Ovarian cancer risk 3-5 x higher

OPTIONS WITH BRCA SURVEILLANCE RISK AVOIDANCE PROPHYLACTIC SURGERY

SURVEILLANCE BREAST CANCER:self examination mammograms MRI OVARIAN CANCER:clinical examinations vaginal ultrasound Ca125 level

RISK AVOIDANCE Reduction in body fat Reduction in alcohol intake Reduced dietary fat Increase physical activity

PROPYHLACTIC SURGERY BILATERAL PROPHYLACTIC MASTECTOMY BILATERAL PROPHYLACTIC SALPINGO- OOPHORECTOMY

PROPHYLACTIC BILATERAL MASTECTOMY Complete removal of both breasts Including nipples:TOTAL MASTECTOMY Nipple conservation:NIPPLE SPARING MASTECTOMY

TOTAL BILATERAL MASTECTOMY WITHOUT RECONSTRUCTION

TOTAL BILATERAL MASTECTOMY WITH RECONSTRUCTION IN PROGRESS

TOTAL BILATERAL MASTECTOMY WITH COMPLETED RECONSTRUCTION

CANDIDATES FOR P.MASTECTOMY Known BRCA1 and BRCA2 mutations Strong family history without BRCA mutations Lobular carcinoma in situ(LCIS)+family history Radiation to chest wall before 30 years of age Cancer in one breast

BENEFITS OF P. MASTECTOMY BRCA1 BRCA2 MUTATIONS Expected risk reduction of 95% STRONG FAMILY HISTORY Expected risk reduction of 90%

DRAWBACKS OF P.MASTECTOMY Irreversible Expensive :multiple operations time consuming days off work Procedure related complications:infection bleeding Psychological:change in body image

BILATERAL PROPHYLACTIC SALPINGO-OOPHORECTOMY (BSO) Removing both the ovaries and fallopian tubes

TECHNIQUES FOR BSO

CANDIDATES FOR BSO High risk women BRCA 1 and BRCA 2 mutations Premenopausal Older than 35 Completed families

BENEFITS OF BSO IN HIGH RISK WOMEN Expected risk reduction of ovarian cancer 90% Expected risk reduction of breast cancer 50%

DRAWBACKS OF BSO Permanent and irreversible Surgical complications:infection ; haemorrhage ;intestinal obstruction Immediate surgically induced menopause discomforts osteoporosis heart disease memory loss and dementia

BSO AT WHAT COST ? WITH NO HRT Higher rate of premature death,cancer, heart disease and neurological disease HRT?????????

CONCLUSION RISK REDUCING SURGERY FOR ALL?